Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–67
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
scheduled to undergo Bilateral nerve-sparing radical prostatectomy (BNSRP) for organ-confined, non-metastatic prostate cancer
have a normal preoperative erectile function score of more or equal to 22 at screening(as evaluated by International Index of Erectile Function - Erectile Function domain (IIEF-EF))
develop Erectile Dysfunction (ED) (defined as the consistent inability to achieve and/or maintain an erection sufficient to permit satisfactory sexual intercourse) after surgery
have an interest in resuming sexual activity as soon as possible after surgery and anticipate having the same adult female sexual partner during the study
agree not to use any other treatment for ED, including herbal and over-the-counter (OTC) medications, during the study
does not require the initiation of adjuvant therapy for prostate cancer
You may not be if
history of ED
have received previous or current treatment with tadalafil or any other Phosphodiesterase Type 5 (PDE5) inhibitor
have undergone, or plan to undergo, radiation or hormonal therapy for prostate cancer
have a history of prostatic surgery or prostatic physical treatments
have a history of diabetes mellitus
have a history of galactose intolerance, lapp lactase deficiency, or glucose-galactose malabsorption
have clinically significant renal insufficiency as determined by the investigator